CompaniesABAC Therapeutics

ABAC Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

40

By Phase

PHASE2: 1

By Status

UNKNOWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
Today
NCT03899324
Hover over trial bars to see details

Recent Trials

NCT03899324Lead Sponsor
Evaluation of the Efficacy and Safety of Bumetanide in Parkinson's Disease
PHASE2Unknown
40 participants
Started: Apr 26, 2019 · Completed: Aug 31, 2021